Dong-A sees increased earnings for 1Q

Published: 2009-04-27 06:58:00

Updated: 2009-04-27 06:58:00

Steadily improving brand recognition and regaining price competitiveness due to intensified cost-cutting efforts have helped boost the sales of Dong-A Pharmaceutical Co. in the first three months of the year

Although worries over Korean won’s fall against dollar still burdening major pharmaceu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK